Filip Babić, P. Čačić, Dominik Kralj, A. Bišćanin, V. Tomašić, I. Burčul, Doris Ogresta Kordej, Z. Dorosulić, D. Hrabar
{"title":"老年炎症性肠病患者：患者和疾病特征","authors":"Filip Babić, P. Čačić, Dominik Kralj, A. Bišćanin, V. Tomašić, I. Burčul, Doris Ogresta Kordej, Z. Dorosulić, D. Hrabar","doi":"10.26800/lv-145-supl9-25","DOIUrl":null,"url":null,"abstract":"Results : A total of 184 non-elderly and 11 elderly patients were analyzed. Baseline IBD patient and disease characteristics were comparable in elderly and non-elderly group as there was no statistically significant difference in female or smoking rates, as well as in disease duration or extraintestinal manifestations rates. When comparing treatment data, anti-TNFα drugs were used significantly less in the elderly group (p=0.001). Combination therapy with an immunomodulator and a biologic (combotherapy) was evaluated on patients starting anti-TNFα drugs and was significantly higher in the non-elderly patient group (p=0.02","PeriodicalId":246678,"journal":{"name":"Liječnički vjesnik","volume":" 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Elderly inflammatory bowel disease patients: patient and disease characteristics\",\"authors\":\"Filip Babić, P. Čačić, Dominik Kralj, A. Bišćanin, V. Tomašić, I. Burčul, Doris Ogresta Kordej, Z. Dorosulić, D. Hrabar\",\"doi\":\"10.26800/lv-145-supl9-25\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Results : A total of 184 non-elderly and 11 elderly patients were analyzed. Baseline IBD patient and disease characteristics were comparable in elderly and non-elderly group as there was no statistically significant difference in female or smoking rates, as well as in disease duration or extraintestinal manifestations rates. When comparing treatment data, anti-TNFα drugs were used significantly less in the elderly group (p=0.001). Combination therapy with an immunomodulator and a biologic (combotherapy) was evaluated on patients starting anti-TNFα drugs and was significantly higher in the non-elderly patient group (p=0.02\",\"PeriodicalId\":246678,\"journal\":{\"name\":\"Liječnički vjesnik\",\"volume\":\" 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Liječnički vjesnik\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26800/lv-145-supl9-25\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Liječnički vjesnik","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26800/lv-145-supl9-25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Elderly inflammatory bowel disease patients: patient and disease characteristics
Results : A total of 184 non-elderly and 11 elderly patients were analyzed. Baseline IBD patient and disease characteristics were comparable in elderly and non-elderly group as there was no statistically significant difference in female or smoking rates, as well as in disease duration or extraintestinal manifestations rates. When comparing treatment data, anti-TNFα drugs were used significantly less in the elderly group (p=0.001). Combination therapy with an immunomodulator and a biologic (combotherapy) was evaluated on patients starting anti-TNFα drugs and was significantly higher in the non-elderly patient group (p=0.02
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
